Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2026-08-14 17:40:33 ET · period of report 2026-08-14 · accession 0001724161-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 17:40 | 2026-08-14 | CAI | Vacirca Jeff L | Dir | A - Grant | $0.00 | +13.2K | 62.9K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | A | A | 13,192 | $0.00 | 62,863 | D | — | — | (F1) Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |